Sentinel node biopsy in head and neck squamous cell carcinoma

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 17, Issue 2, 2009, Pages 100-110

  Kuriakose, Moni Abraham ^a   Trivedi, Nirav P ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Head and neck cancer; Lymphoscintigraphy; Micrometastasis; Neck dissection; Occult metastasis; Oral cancer; Sentinel node biopsy; Squamous cell carcinoma

Indexed keywords

DYE; EOSIN; HEMATOXYLIN; IODINE 131; RADIOISOTOPE; TECHNETIUM 99M;

CANCER STAGING; CYTOLOGY; DRUG HALF LIFE; FROZEN SECTION; HEAD AND NECK CARCINOMA; HUMAN; IMMUNOHISTOCHEMISTRY; INTRAOPERATIVE PERIOD; ISOTOPE LABELING; LYMPHOSCINTIGRAPHY; MOUTH CAVITY; NECK DISSECTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SCINTILLATION CAMERA; SENSITIVITY ANALYSIS; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; STAINING; TUMOR LOCALIZATION;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; OROPHARYNGEAL NEOPLASMS; SENTINEL LYMPH NODE BIOPSY;

EID: 67849085427     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOO.0b013e3283293631     Document Type: Review

References (100)

1. van den Brekel MW, van der Waal I, Meijer CJ, et al. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope 1996; 106:987-991.
2. Teichgraeber JF, Clairmont AA. The incidence of occult metastases for cancer of the oral tongue and floor of the mouth: treatment rationale. Head Neck 1984; 7:15-21.
3. Hosal AS, Carrau RL, Johnson JT, Myers EN. Selective neck dissection in the management of the clinically node-negative neck. Laryngoscope 2000; 110:2037-2040.
4. Leemans CR, Tiwari RM, Nauta JJP, et al. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer 1993; 71:452-456.
5. Noguchi M, Kido Y, Kubota H, et al. Prognostic factors and relative risk for survival in N1-3 oral squamous cell carcinoma: a multivariate analysis using Cox's hazard model. Br J Oral Maxillofac Surg 1999; 37:433-437. (Pubitemid 30066187)
6. Mamelle G, Pampurik J, Luboinski B, et al. Lymph node prognostic factors in head and neck squamous cell carcinomas. Am J Surg 1994; 168:494-498. (Pubitemid 24345707)
7. Haddadin KJ, Soutar DS, Oliver RJ, et al. Improved survival for patients with clinically T1/T2, N0 tongue tumors undergoing a prophylactic neck dissection. Head Neck 1999; 21:517-525.
8. Woolgar JA, Beirne JC, Vaughn ED, et al. Correlation of histopathologic findings with clinical and radiologic assessments of cervical lymph-node metastases in oral cancer. Int J Oral Maxillofac Surg 1995; 24:30-37.
9. Stacker SA, Achen MG, Jussila L, et al. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002; 2:573-583.
10. Luk SC, Nopajaroonsri C, Simon GT. The architecture of the normal lymph node and hemolymph node. A scanning and transmission electron microscopic study. Lab Invest 1973; 29:258-265.
11. Shah JP, Candela FC, Poddar AK. The patterns of cervical lymph node metastases from squamous carcinoma of the oral cavity. Cancer 1990; 66:109-113. (Pubitemid 20197093)
12. Lindberg R. Distribution of cervical lymph node metastases from squamous cell carcinoma of the upper respiratory and digestive tracts. Cancer 1972; 29:1446-1450.
13. Alvi A, Johnson JT. Extracapsular spread in the clinically negative neck (N0): implications and outcome. Otolaryngol Head Neck Surg 1996; 114:65-70.
14. Seaman WB, Powers WE. Studies on the distribution of radioactive colloidal gold in regional lymph nodes containing cancer. Cancer 1955; 8:1044-1046.
15. Gould EA, Winship T, Philbin PH, et al. Observations on a 'sentinel node' in cancer of the parotid. Cancer 1960; 13:77-78.
16. Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39:456-466.
17. Wespes E, Simon J, Schulman CC. Cabanas approach: is sentinel node biopsy reliable for staging penile carcinoma? Urology 1986; 28:278-279.
18. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphaticmapping for early stage melanoma. Arch Surg 1992; 127:392-399.
19. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin North Am 1996; 5:33-41. (Pubitemid 26049994)
20. Morton DL, Thompson JF, Essner R, et al., Multicenter Selective Lymphadenectomy Trial Group. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg 1999; 230:453-463. [discussion 463-465].
21. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5:255-260.
22. Pijpers R, Collet GJ, Meijer S, et al. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995; 22:1238-1241.
23. Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinal lymphadenectomy. Ann Surg 1995; 222:394-401.
24. Hamy A, Curtet C, Paineau J, et al. Feasibility of radioimmunoguided surgery of colorectal carcinoma using indium 111 CEA specific antibody and simulation with a phantom using 2 step targeting with bispecific antibody. Tumori 1995; 81:103-106.
25. Levenback C, Burke TW, Morris M, et al. Potential application of intraoperative lymphatic mapping in vulval cancer. Gynecol Oncol 1995; 59:216-220.
26. Kitagawa Y, Fujii H, Mukai M, et al. The role of the sentinel lymph node in gastrointestinal cancer. Surg Clin North Am 2000; 80:1799-1809. (Pubitemid 32006394)
27. Tanis PJ, Lont AP, Meinhardt W, et al. Dynamic sentinel node biopsy for penile cancer: reliability of a staging technique. J Urol 2002; 168:76-80. (Pubitemid 34640787)
28. Liptay MJ, Masters GA, Winchester DJ, et al. Intraoperative radioisotope sentinel lymph node mapping in nonsmall cell lung cancer. Ann Thorac Surg 2000; 70:384-389. [discussion 389-390].
29. Wawroschek F, Vogt H, Weckermann D, et al. The sentinel lymph node concept in prostate cancer: first results of gamma probe-guided sentinel lymph node identification. Eur Urol 1999; 36:595-600. (Pubitemid 29516291)
30. Messina JL, Reintgen DS, Cruse CW, et al. Selective lymphadenectomy in patients with Merkel cell (cutaneous neuroendocrine) carcinoma. Ann Surg Oncol 1997; 4:389-395. (Pubitemid 127725513)
31. Alex JC. The application of sentinel node radiolocalization to solid tumors of the head and neck: a 10-year experience. Laryngoscope 2004; 114:2-19.
32. Civantos FJ, Moffat FL, Goodwin WJ. Lymphatic mapping and sentinel lymphadenectomy for 106 headandneck lesions: contrasts between oral cavity and cutaneous malignancy. Laryngoscope 2006; 116 (Suppl 109):1-15.
33. Werner JA, Dunne AA, Ramaswamy A, et al. The sentinel node concept in head and neck cancer: solution for controversies in the N0 neck? Head Neck 2004; 26:603-611.
34. Stern WB, Silver CE, Zeifer BA, et al. Computed tomography of the clinically negative neck. Head Neck 1990; 12:109-113.
35. Friedman M, Mafee MF, Pacella BL Jr, et al. Rationale for elective neck dissection in 1990. Laryngoscope 1990; 100:54-59.
36. Moreau P, Goffart Y, Collignon J. Computed tomography of metastatic cervical lymph nodes. A clinical, computed tomographic, pathologic correlative study. Arch Otolaryngol Head Neck Surg 1990; 116:1190-1193.
37. van den Brekel MW, Castelijns JA, Stel HV, et al. Modern imaging techniques and ultrasound-guided aspiration cytology for the assessment of neck node metastases: a prospective comparative study. Eur Arch Otorhinolaryngol 1993; 250:11-17.
38. Righi PD, Kopecky KK, Caldemeyer KS, et al. Comparison of ultrasound-fine needle aspiration and computed tomography in patients undergoing elective neck dissection. Head Neck 1997; 19:604-610.
39. Takes RP, Knegt P, Manni JJ, et al. Regional metastasis in head and neck squamous cell carcinoma: revised value of US with US-guided FNAB. Radiology 1996; 198:819-823. (Pubitemid 26066304)
40. Don DM, Anzai Y, Lufkin RB, et al. Evaluation of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Laryngoscope 1995; 105:669-674.
41. Alkureishi LWT, Ross GL, MacDonald G, et al. Sentinel nodes in head and neck cancer: use of size criterion to upstage the N0 neck in head and neck squamous cell carcinoma. Head Neck 2007; 29:95-103. This study shows that size of a lymph node is not an accurate predictor of presence of occult metastasis using SNB-guided neck dissection.
42. Hyde NC, Prvulovich E, Newman L, et al. A new approach to pretreatment assessment of the N0 neck in oral squamous cell carcinoma: the role of sentinel node biopsy and positron emission tomography. Oral Oncol 2003; 39:350-360. (Pubitemid 36379342)
43. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Is there a role for positron emission tomography with 18F-Fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck 2002; 24:345-349. (Pubitemid 34260038)
44. Byers RM, Weber RS, Andrews T, et al. Frequency and therapeutic implications of 'skip metastases' in the neck from squamous cell carcinoma of the oral tongue. Head Neck 1997; 19:14-19.
45. Pitman KT, Johnson JT, Edington H, et al. Lymphatic mapping with isosulfan blue dye in squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg 1998; 124:790-793.
46. Shoaib T, Soutar DS, Prosser JE, et al. A suggested method for sentinel node biopsy in squamous cell carcinoma of the head and neck. Head Neck 1999; 21:728-733.
47. Koch WM, Choti MA, Civelek AC, et al. Gamma probe-directed biopsy of the sentinel node in oral squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1998; 124:455-459. (Pubitemid 28178320)
48. Shoaib T, Soutar DS, MacDonald DG, et al. The accuracy of head and neck cancer sentinel node biopsy in the clinically N0 neck. Cancer 2001; 91:2077-2083. (Pubitemid 32476372)
49. Alex JC, Sasaki CT, Krag DN, et al. Sentinel lymph node radiolocalization in head and neck squamous cell carcinoma. Laryngoscope 2000; 110:198-203.
50. Chiesa F, Mauri S, Grana C, et al. Is there a role for sentinel node biopsy in early N0 tongue tumors? Surgery 2000; 128:16-21.
51. Zitsch RP III, Todd DW, Renner GJ, Singh A. Intraoperative radiolymphoscintigraphy for detection of occult nodal metastasis in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2000; 122:662-666. (Pubitemid 30333841)
52. Ross G, Shoaib T, Soutar D, et al. The use of sentinel node biopsy to upstage the clinically N0 neck in head and neck cancer. Arch Otolaryngol Head Neck Surg 2002; 128:1287-1291. (Pubitemid 35403308)
53. Kontio R, Leivo I, Leppanen E, Atula T. Sentinel lymph node biopsy in oral cavity squamous cell carcinoma without clinically evident metastasis. Head Neck 2004; 26:16-21. (Pubitemid 38030145)
54. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Sentinel lymph node evaluation in squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg 2001; 125:221-226. (Pubitemid 33662671)
55. Taylor RJ, Wahl RL, Sharma PK, et al. Sentinel node localization in oral cavity and oropharynx squamous cell cancer. Arch Otolaryngol Head Neck Surg 2001; 127:970-974. (Pubitemid 32717737)
56. Pitman KT, Johnson JT, Brown ML, Myers EN. Sentinel lymph node biopsy in head and neck squamous cell carcinoma. Laryngoscope 2002; 112:2101-2113. (Pubitemid 35417031)
57. Altinyollar H, Berberoglu U, Celen O. Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip. Eur J Surg Oncol 2002; 28:72-74. (Pubitemid 41122787)
58. Barzan L, Sulfaro S, Alberti F, et al. Gamma probe accuracy in detecting the sentinel lymph node in clinically N0 squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 2002; 111:794-798. (Pubitemid 35034275)
59. Ionna F, Chiesa F, Longo F, et al. Prognostic value of sentinel node in oral cancer. Tumori 2002; 88:S18-S19. (Pubitemid 34875465)
60. Pastore A, Turetta GD, Tarabini A, et al. Sentinel lymph node analysis in squamous carcinoma of the oral cavity and oropharynx. Tumori 2002; 88:S58-S60. (Pubitemid 34875487)
61. Werner JA, Dunne AA, Ramaswamy A, et al. Sentinel node detection in N0 cancer of the pharynx and larynx. Br J Cancer 2002; 87:711-715. (Pubitemid 35178746)
62. Kohno N, Ohno Y, Kihara K, et al. Feasibility of sentinel lymph node radiolocalization in neck node-negative oral squamous cell carcinoma patients. ORL J Otorhinolaryngol Relat Spec 2003; 65:66-70. (Pubitemid 36302457)
63. Hoft S, Maune S, Muhle C, et al. Sentinel lymph-node biopsy in head and neck cancer. Br J Cancer 2004; 91:124-128. (Pubitemid 39013056)
64. Hart RD, Nasser JG, Trites JR, et al. Sentinel lymph node biopsy in N0 squamous cell carcinoma of the oral cavity and oropharynx. Arch Otolaryngol Head Neck Surg 2005; 131:34-38. (Pubitemid 40105458)
65. Kovács AF, Landes CA, Hamscho N, et al. Sentinel node biopsy as a staging tool in a multimodality treatment approach to cancer of the oral cavity and the oropharynx. Otolaryngol Head Neck Surg 2005; 132:570-576. (Pubitemid 40460885)
66. Werner JA, Dunne AA, Ramaswamy A, et al. Number and location of radiolabeled, intraoperatively identified sentinel nodes in 48 head and neck cancer patients with clinically staged N0 and N1 neck. Eur Arch Otorhinolaryngol 2002; 259:91-96. (Pubitemid 34185609)
67. Asthana S, Deo SVS, Shukla NK, et al. Intraoperative neck staging using sentinel node biopsy and imprint cytology in oral cancer. Head Neck 2003; 25:368-372. (Pubitemid 36461110)
68. Ross GL, Soutar DS, MacDonald DG, et al. Sentinel node biopsy in head and neck cancer: preliminary results of a multicenter trial. Ann Surg Oncol 2004; 11:690-696.
69. Gallegos-Hernandez JF, Hernandez-Hernandez DM, Flores-Diaz R, et al. The number of sentinel nodes identified as prognostic factor in oral epidermoid cancer. Oral Oncol 2005; 41:947-952. (Pubitemid 41265955)
70. Alkureishi L, Ross G, Shoaib T, et al. Sentinel node biopsy as a staging tool in early head and neck squamous cell cancer: long term follow up of a multicenter trial [abstract #078]. Oral Oncol Suppl May 2007. Abstract book of First World Congress of the International Academy of Oral Oncology (IAOO); 2007.
71. Stockeli SJ. Sentinel node biopsy for oral and oropharyngeal squamous cell carcinoma of the head and neck. Laryngoscope 2007; 117:1539-1551. Candidate thesis, detailed outline of current technique for lymphoscintigraphy and technique for step sectioning.
72. Bilde A, von Buchwald C, Therkildsen MH, et al. Need for intensive histopathologic analysis to determine lymph node metastases when using sentinel node biopsy in oral cancer. Laryngoscope 2008; 118:408-414. This study highlights the need for more intense pathological evaluation of a sentinel node. (Pubitemid 351640630)
73. Ross GL, Shoaib T, Soutar DS, et al. The First International Conference on Sentinel node biopsy in mucosal head and neck cancer and adoption of a multicenter trial protocol. Ann Surg Oncol 2002; 9:406-410. (Pubitemid 34496730)
74. Paleri V, Rees G, Arullendran P, et al. Sentinel node biopsy in squamous cell cancer of the oral cavity and oral pharynx: a diagnostic meta-analysis. Head Neck 2005; 27:739-747. (Pubitemid 41266177)
75. McMasters KM, Reintgen DS, Ross MI, et al. Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed? Ann Surg Oncol 2001; 8:192-197.
76. Sherman AI, Ter-Pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer 1953; 6:1238-1240.
77. Strand SE, Persson BR. Quantitative lymphoscintigraphy I: basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979; 20:1038-1046.
78. Devaney SL, Ferlito A, Rinaldo A, et al. The pathology of neck dissection in cancer of the larynx. ORL J Otorhinolaryngol 2000; 62:204-211. (Pubitemid 30414978)
79. Stoeckli SJ, Pfaltz M, Ross GL, et al. The Second International Conference on sentinel node biopsy in mucosal head and neck cancer. Ann Surg Oncol 2005; 12:919-924. (Pubitemid 41504225)
80. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998; 16:2253-2260.
81. Xu X, Roberts SA, Pasha TL, Zhang PJ. Undesirable cytokeratin immunoreactivity of native nonepithelial cells in sentinel lymph nodes from patients with breast carcinoma. Arch Pathol Lab Med 2000; 124:1310-1313. (Pubitemid 30694084)
82. Domagala W, Bedner E, Chosia M, et al. Keratin-positive reticulum cells in fine needle aspirates and touch imprints of hyperplastic lymph nodes. A possible pitfall in the immunocytochemical diagnosis of metastatic carcinoma. Acta Cytol 1992; 36:241-245.
83. Hermanek P, Hutter RVP, Sobin LH, Wittekind C. Classification of isolated tumor cells and micrometastasis. Cancer 1999; 86:2668-2673. (Pubitemid 30004671)
84. American Joint Committee on Cancer. Cancer staging manual. 6th ed. New York (New York): Springer; 2002. pp. 223-240.
85. Ferlito A, Partridge M, Brennan J, et al. Lymph node micrometastases in head and neck cancer: a review. Acta Otolaryngol 2001; 121:660-665. (Pubitemid 32964356)
86. Devaney KO, Rinaldo A, Ferlito A. Micrometastasis in cervical lymphnodes from patients with squamous carcinoma of the head and neck: should they be actively sought? Am J Otolaryngol Head Neck Surg Med 2007; 28:271-274. This study demonstrates the clinical significance of micrometastasis.
87. Stoeckli SJ, Pfaltz M, Steinert H, Schmid S. Histopathological features of occult metastasis detected by sentinel lymph node biopsy in oral and oropharyngeal squamous cell carcinoma. Laryngoscope 2002; 112:111-115. (Pubitemid 34037746)
88. Muhle C, Brener W, Sudmeyer M, et al. CT-guided lymphoscintigraphy in patients with squamous cell carcinoma of the head and neck: a feasibility study. Eur J Nucl Med Mol Imaging 2004; 31:940-944. (Pubitemid 38915647)
89. Trivedi NP, Kuriakose MA, Hiran KR, et al. Relative efficacy of histopathology, IHC and RTPCR for the detection of occult metastasis in sentinel lymph nodes [abstract #S055]. In: Proceedings of 7th International Conference on Head and Neck cancer - 2008; 2008. pp. 119. A detailed analysis of different methods of pathological evaluation for sentinel node and their relative efficacy in identifying occult metastasis.
90. Tschopp L, Nuyens M, Stauffer E, et al. The value of frozen section analysis of the sentinel lymph node in clinically N0 squamous cell carcinoma of the oral cavity and oropharynx. Otolaryngol Head Neck Surg 2005; 132:99-102. (Pubitemid 40052679)
91. Hamakawa H, Onishi A, Sumida T, et al. Intraoperative real-time genetic diagnosis for sentinel node navigation surgery. Int J Oral Maxillofac Surg 2004; 33:670-675. (Pubitemid 39186157)
92. Shivers SC, Wang X, Li W, et al. Molecular staging of malignant melanoma: correlation with clinical outcome. JAMA 1998; 280:1410-1415. (Pubitemid 28496047)
93. Woolgar JA. Micrometastasis in oral/oropharyngeal squamous cell carcinoma: incidence, histopathological features and clinical implications. Br J Oral Maxillofac Surg 1999; 37:181-186.
94. Yamazaki Y, Chiba I, Hirai A, et al. Clinical value of genetically diagnosed lymph node micrometastases for patients with oral squamous cell carcinoma. Head Neck 2005; 27:676-681. (Pubitemid 41113768)
95. Colnot DR, Nieuwenhuis EJC, Kuik DJ, et al. Clinical significance of micrometastatic cells detected by E48 (Ly-6D) reverse transcriptase: polymerase chain reaction in bone marrow of head and neck cancer patients. Clin Cancer Res 2004; 10:7827-7833.
96. Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma: past, present and future. Ann Surg Oncol 2001; 8 (9 Suppl):22S-28S.
97. Hart RD, Nasser JG, Trites JR, et al. Sentinel node biopsy in N0 squamous cell carcinoma of the oral cavity and oropharynx in patients previously treated with surgery or radiation therapy. Arch Otolaryngol Head Neck Surg 2007; 133:806-809. A pilot study in previously treated patients.
98. Nason RW, Torchia MG, Morales CM, Thliveris J. Dynamic MR lymphangiography and carbon dye for sentinel node detection: a solution for sentinel lymphnode biopsy in mucosal head and neck cancer. Head Neck 2005; 27:333-338. (Pubitemid 40418606)
99. Klutmann S, Bohuslavizki KH, Brenner W, et al. Lymphoscintigraphy in tumors of the head and neck using double tracer technique. J Nucl Med 1999; 40:776-782. (Pubitemid 29210751)
100. Wener JA, Sapundzhiev NR, Teymoortash A, et al. Endoscopic sentinel lymphadenectomy as a new diagnostic approach in the N0 neck. Eur Arch Otorhinolaryngol 2004; 261:463-468. (Pubitemid 39506421)